Cencora (COR) vs Herbalife (HLF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Herbalife (HLF) has outperformed Cencora (COR) over the past year, gaining 42.8% versus a gain of 2.8%. Over five years, COR leads with a +164.7% price change compared with -70.9% for HLF. Cencora is the larger company by market cap ($60.54 billion vs $1.31 billion), about 46.2 times the size.
On valuation, Herbalife trades at a lower forward P/E (4.1x vs 16.0x for Cencora). Cencora pays a dividend yielding 0.74%, while Herbalife does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | HLF |
|---|---|---|
| Share price | $317.25 | $12.65 |
| Market cap | $60.54B | $1.31B |
| 1-day change | +0.28% | +0.56% |
| YTD return | -6.07% | -1.86% |
| 1-year return | +2.77% | +42.78% |
| 5-year return | +164.68% | -70.91% |
| P/E ratio (TTM) | 23.55 | 8.06 |
| Forward P/E | 16.02 | 4.11 |
| EPS (TTM) | $13.47 | $1.57 |
| Dividend yield | 0.74% | 0.00% |
| Annual dividend | $2.35 | $0.00 |
| Revenue (latest FY) | $321.33B | — |
| Revenue growth (YoY) | +9.31% | — |
| Net income (latest FY) | $1.55B | — |
| Gross margin | 3.57% | — |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | — |
| 52-week high | $377.54 | $20.40 |
| 52-week low | $244.82 | $7.56 |
| Distance from 52-week high | -15.97% | -37.99% |
| Analyst consensus | buy | none |
| Avg. price target upside | +16.39% | +34.39% |
| Average volume | 1.33M | 1.54M |
| Shares outstanding | 190.83M | 103.67M |
| Employees | 47,000 | 8,500 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 46.2 times larger than Herbalife by market value ($60.54B vs $1.31B).
- HLF has outperformed COR by 40.0 percentage points over the past year.
- Cencora trades at a higher earnings multiple (23.6x vs 8.1x trailing P/E).
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
About Herbalife
HLF stock →Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products.
Health Care · Other Pharmaceuticals · 8,500 employees
COR vs HLF FAQ
Which is bigger, Cencora or Herbalife?
Cencora (COR) is larger, with a market capitalization of $60.54B compared with $1.31B for Herbalife (HLF).
Which stock has performed better over the past year, COR or HLF?
HLF returned +42.78% over the past 12 months, compared with +2.77% for COR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, COR or HLF?
HLF has the lower trailing P/E at 8.1, versus 23.6 for COR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cencora or Herbalife?
Cencora pays a dividend yielding 0.74%, while Herbalife does not currently pay a regular dividend.
Are Cencora and Herbalife in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.